Met Life Investment Management, LLC Precision Biosciences Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.96 - $7.76 $56,358 - $147,750	-19,040 Closed	0 $0
Q4 2021 May 17, 2024	BUY	$7.4 - $11.66 $50,949 - $80,279	6,885 Added 56.64%	19,040 $140,000
Q4 2021 Jun 21, 2023	BUY	$7.4 - $11.66 $140,896 - $222,006	19,040 New	19,040 $140,000
Q4 2021 Mar 22, 2023	BUY	$7.4 - $11.66 $50,949 - $80,279	6,885 Added 56.64%	19,040 $140,000
Q4 2021 Feb 15, 2022	BUY	$7.4 - $11.66 $50,949 - $80,279	6,885 Added 56.64%	19,040 $141,000
Q3 2021 May 17, 2024	SELL	$9.18 - $14.15 $59,917 - $92,357	-6,527 Reduced 34.94%	12,155 $140,000
Q3 2021 Jun 21, 2023	BUY	$9.18 - $14.15 $111,582 - $171,993	12,155 New	12,155 $140,000
Q3 2021 Mar 22, 2023	SELL	$9.18 - $14.15 $59,917 - $92,357	-6,527 Reduced 34.94%	12,155 $140,000
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $59,917 - $92,357	-6,527 Reduced 34.94%	12,155 $140,000
Q2 2021 May 17, 2024	BUY	$8.07 - $12.52 $81,289 - $126,113	10,073 Added 117.01%	18,682 $233,000
Q2 2021 Mar 22, 2023	BUY	$8.07 - $12.52 $81,289 - $126,113	10,073 Added 117.01%	18,682 $233,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $81,289 - $126,113	10,073 Added 117.01%	18,682 $234,000
Q1 2021 May 17, 2024	BUY	$8.57 - $15.79 $73,779 - $135,936	8,609 New	8,609 $89,000
Q1 2021 Jun 26, 2023	BUY	$8.57 - $15.79 $73,779 - $135,936	8,609 New	8,609 $89.1 Million
Q1 2021 Mar 22, 2023	SELL	$8.57 - $15.79 $108,719 - $200,311	-12,686 Reduced 59.57%	8,609 $89,000
Q1 2021 May 14, 2021	SELL	$8.57 - $15.79 $108,719 - $200,311	-12,686 Reduced 59.57%	8,609 $89,000
Q4 2020 May 24, 2024	SELL	$5.98 - $12.47 $35,431 - $73,884	-5,925 Reduced 21.77%	21,295 $177,000
Q4 2020 Jun 22, 2023	BUY	$5.98 - $12.47 $127,344 - $265,548	21,295 New	21,295 $177,000
Q4 2020 Mar 22, 2023	SELL	$5.98 - $12.47 $35,431 - $73,884	-5,925 Reduced 21.77%	21,295 $177,000
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $35,431 - $73,884	-5,925 Reduced 21.77%	21,295 $178,000
Q3 2020 Jun 26, 2023	BUY	$4.65 - $8.73 $126,573 - $237,630	27,220 New	27,220 $167,000
Q2 2020 May 24, 2024	BUY	$4.66 - $8.7 $126,845 - $236,813	27,220 New	27,220 $227 Million
Q2 2020 Jun 26, 2023	BUY	$4.66 - $8.7 $126,845 - $236,813	27,220 New	27,220 $226,000
Q2 2020 Mar 22, 2023	BUY	$4.66 - $8.7 $46,408 - $86,643	9,959 Added 57.7%	27,220 $226,000
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $46,408 - $86,643	9,959 Added 57.7%	27,220 $227,000
Q1 2020 Jul 12, 2023	BUY	$5.05 - $15.01 $87,168 - $259,087	17,261 New	17,261 $104,000
Q4 2019 Jul 12, 2023	BUY	$6.32 - $19.66 $109,089 - $339,351	17,261 New	17,261 $239,000
Q4 2019 Mar 22, 2023	BUY	$6.32 - $19.66 $109,089 - $339,351	17,261 New	17,261 $239,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $109,089 - $339,351	17,261 New	17,261 $240,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.66 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.06 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.97 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.13 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$779,657
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $559M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account